We are absolutely thrilled to announce that the team at Re:Cognition Health have been shortlisted as finalists for two categories in the very prestigious LaingBuisson Awards.
As a leading provider of brain and mind services and world-leading centre for international clinical trials, Re:Cognition Health has been shortlisted in the Primary Care & Diagnostics category, which recognises excellence in the delivery of healthcare services.
Dr Emer MacSweeney, CEO, Medical Director and Consultant Neuroradiologist at Re:Cognition Health has also been shortlisted in the Rising Star category, which acknowledges the highest level of talent in the health and social care sectors.
The expert team at Re:Cognition Health manage a wide range of conditions from autism and ADHD to Alzheimer’s disease and Traumatic Brain Injury, using the latest research and evidence based treatment plans to achieve the very best patient outcomes. Re:Cognition Health is recognised as the fasted growing company, globally, providing clinical trials for Alzheimer’s disease and all other causes of dementia. The team also provide numerous free educational and professional presentations to the public, clinicians, healthcare workers and the legal profession in our areas of expertise, helping to educate, inform and share knowledge. We are dedicated to changing the future and proud to be spearheading research and innovation in our fields.
The LaingBuisson Awards are the Oscars of health and social care and recognise excellence in these sectors and we are delighted to be celebrating with the industry and being part of such prestigious awards.